Pubdate: Wed, 23 Mar 2005 Source: Times-Picayune, The (LA) Copyright: 2005 The Times-Picayune Contact: http://www.nola.com/t-p/ Details: http://www.mapinc.org/media/848 Author: Ed Anderson, Capital bureau Bookmark: http://www.mapinc.org/meth.htm (Methamphetamine) SENATE MEASURE AIMED AT ILLEGAL METH LABS Ammonia, Sinus Medicine Sales Limited BATON ROUGE -- Legislation aimed at cracking down on illegal methamphetamine manufacturing labs by making it harder to obtain over-the-counter sinus medication and ammonia, two of the main ingredients used in making the drug, was filed Tuesday by Sen. James David Cain, R-Dry Creek. Cain's Senate Bill 24 would prohibit retail stores and pharmacies from selling or displaying more than three packages, or 9 grams, of over-the-counter medicines containing ephedrine, pseudoephedrine or phenylpropanolamine, the main components in sinus medication and some cold medicines. The bill allows the sale of the drugs if prescribed by a doctor. The bill also says that if someone buys medications with ephedrine compounds in them, the purchaser must produce a photo identification with proof of age, and sign a receipt indicating the date of the purchase and how much was bought. The bill also prohibits the sale of more than 9 grams every 30 days, unless a doctor prescribes otherwise. Cain's bill gives the state Department of Health and Hospitals the authority to draft regulations exempting substances from the proposal if they cannot be used in the illegal manufacturing of methamphetamines or other illegal drugs. Violators could face up to two years in jail, up to a $2,000 fine or both if convicted. If a retailer has more displays or sells more than three packages of the substances to the same person without a prescription, he or she could be fined up to $500 for a first offense and up to $1,000 for subsequent violations. The bill also creates the crime of unauthorized possession of anhydrous ammonia, a volatile substance used legitimately by farmers and often stolen by meth lab operators. Cain's bill would require the dealers of ammonia to inspect their customers' tanks and label them as legal for one year. If a person is found in possession of an unlabeled tank or is caught using the ammonia for making drugs, the individual could be charged with illegal possession of the substance and face up to a $2,000 fine, a maximum two years in jail or both. About a dozen states have passed similar laws. So far, 89 bills have been filed for the legislative session that begins April 25: 60 in the House and 29 in the Senate. On a fiscal issue, Sen. Jay Dardenne, R-Baton Rouge, Tuesday filed SB 23 that phases out the gift tax during the next five years and eliminates it by July 1, 2009. The tax, which generates between $4 million and $5 million a year for the state, is now set at 2 percent on the first $15,000 of a gift's value and 3 percent in excess of $15,000. Meanwhile, Sen. Butch Gautreaux, D-Morgan City, filed SB 22 requiring all licensed public and private hospitals in the state to issue annual reports of all incidents of infections contracted by patients who did not have the problem when they checked in. Gautreaux's bill would require reporting of infections from surgery, "ventilator-associated pneumonia," central line-related blood infections and urinary tract infections. The hospital-by-hospital report would be made available to the public as well as lawmakers, state regulators and providers starting in 2007, covering data collected in 2006. Violation of the law could result in a fine of $100 per violation per day for each day a violation is not reported, and possibly loss of a license to operate. The Louisiana Hospital Association said it will oppose Gautreaux's bill because hospitals already make public reports on infections contracted in their facilities to the federal government. "This bill goes further and deeper" than the federal government now mandates, said Colette Barrett, vice president of development and member services with the association. "The hospital association is very concerned about patient safety. We oppose reporting which is duplicative and redundant. . . . We would rather spend our efforts and resources on the front end, to prevent infection." - --- MAP posted-by: Terry Liittschwager